...
首页> 外文期刊>The Open Surgery Journal >The Use of Recombinant Coagulation Factor VIIa (NovoSeven?) in SevereDiverticular Bleeding
【24h】

The Use of Recombinant Coagulation Factor VIIa (NovoSeven?) in SevereDiverticular Bleeding

机译:重组凝血因子VIIa(NovoSeven?)在严重憩室出血中的应用

获取原文
           

摘要

We report a 68-year-old man with sigmoid colon carcinoma who previously underwent an anterior resection.Five years later, he developed a severe diverticular bleeding which required multiple blood transfusions. He underwent anemergent low anterior colectomy with a right colostomy to protect the anastomosis. Nine days after the operation, he hadanother severe bleeding. Due to his elderly age and two previous colectomies, recombinant coagulation factor VIIa(rFVIIa) was given to avoid re-operation. The bleeding stopped after two doses of rFVIIa, 80 μg/kg followed by 40 μg/kgone hour later. There was no bleeding recurrence.
机译:我们报告了一个68岁的乙状结肠癌患者,之前曾接受过前切除术。五年后,他发生了严重的憩室出血,需要多次输血。为了进行吻合术,他接受了右结肠造瘘术,进行了紧急的低位前结肠切除术。手术九天后,他又有严重的出血。由于他的高龄和以前的两个骨膜切除术,已给予重组凝血因子VIIa(rFVIIa)以避免再次手术。在两次剂量的rFVIIa,80μg/ kg,然后是40μg/ kgone小时后,出血停止了。没有出血复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号